Company / Operating Margin
ORAMED PHARMACEUTICALS INC. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-639.1%
FY2025
5-year range
-1502.0% / -433.8%
FY2021-FY2025
Trend
+45.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -1561.6% in FY2018 to -433.8% in FY2021.
Based on SEC 10-K filings.
-639.1% in FY2025 with a 5-year CAGR of -97.8%.
Improved from -1502.0% to -639.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +257.1pp
- 5-Year Change
- -97.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin increased 45.7% year-over-year.
- Peak operating margin was recorded in FY2021.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -639.1% | +45.7% |
| FY2024 | -1176.8% | +21.6% |
| FY2023 | -1502.0% | -67.6% |
| FY2022 | -896.1% | -106.6% |
| FY2021 | -433.8% | +19.9% |
| FY2020 | -541.3% | -23.4% |
| FY2019 | -438.6% | +71.9% |
| FY2018 | -1561.6% | -35.6% |
| FY2017 | -1151.8% | -25.0% |
| FY2016 | -921.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026